TH72645A - A combination of an SRC inhibitor kinase and a chemotherapy agent for the treatment of proliferation diseases. - Google Patents
A combination of an SRC inhibitor kinase and a chemotherapy agent for the treatment of proliferation diseases.Info
- Publication number
- TH72645A TH72645A TH401002566A TH0401002566A TH72645A TH 72645 A TH72645 A TH 72645A TH 401002566 A TH401002566 A TH 401002566A TH 0401002566 A TH0401002566 A TH 0401002566A TH 72645 A TH72645 A TH 72645A
- Authority
- TH
- Thailand
- Prior art keywords
- treatment
- combination
- chemotherapy agent
- src inhibitor
- proliferation diseases
- Prior art date
Links
- 230000035755 proliferation Effects 0.000 title abstract 3
- 108091000080 Phosphotransferase Proteins 0.000 title 1
- 229940122924 Src inhibitor Drugs 0.000 title 1
- 239000012829 chemotherapy agent Substances 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 102000020233 phosphotransferase Human genes 0.000 title 1
- 229940079593 drug Drugs 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 125000000217 alkyl group Chemical group 0.000 claims 3
- -1 Lkenyl Chemical group 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims 1
- 229940121375 antifungal agent Drugs 0.000 claims 1
- 239000003429 antifungal agent Substances 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
Abstract
DC60 (04/10/47) เปิดเผยสารผสมและวิธีซึ่งมีประโยชน์ในการรักษาและป้องกันความผิดปกติเกี่ยวกับ การงอกขยาย เปิดเผยสารผสมและวิธีซึ่งมีประโยชน์ในการรักษาและป้องกันความผิดปกติเกี่ยวกับ การงอกขยาย สิทธิบัตรยา DC60 (04/10/47) Disclosed mixtures and methods useful in the treatment and prevention of proliferation disorders; disclosed mixtures and methods useful in the treatment and prevention of proliferation disorders. Drug patent
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH72645A true TH72645A (en) | 2005-11-24 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0308243A (en) | Compound, pharmaceutical formulation, and, methods of treating diabetes, alzheimer's disease, and inhibiting gsk-3 in a mammal | |
| NO20070557L (en) | Phthalazine derivatives as PARP inhibitors | |
| NO20070606L (en) | Inhibitors of IAP | |
| EP1889842A4 (en) | Heterocyclic compound | |
| DE60330895D1 (en) | COMPOUNDS SUITED AS INHIBITORS OF JAK AND OTHER PROTEIN KINASES | |
| NO20073783L (en) | Pyrrolidine Inhibitors for IAP | |
| NO20070529L (en) | Quinazoline dione derivatives as parp inhibitors | |
| WO2006028958A3 (en) | Pyridyl inhibitors of hedgehog signalling | |
| NO20082389L (en) | 2,3,4-triphenylimidazoline derivatives as inhibitors of the interaction between P53 and MDM2 proteins for use as anticancer agents | |
| ATE371656T1 (en) | HETEROARYL-PYRIMIDINE DERIVATIVES AS JAK INHIBITORS | |
| EP1593667A4 (en) | AMIN DERIVATIVE | |
| ATE425160T1 (en) | BENZISOXAZOLE DERIVATIVES THAT ARE PROTEIN KINASE INHIBITORS | |
| TW200615266A (en) | Organic compounds | |
| WO2005110410A3 (en) | Kinase inhibitors as therapeutic agents | |
| WO2001032652A3 (en) | N-substituted carbamoyloxyalkyl-azolium derivatives | |
| NO20051695L (en) | Novel spirocondensed quinazolinones and their use as phosphodiesterase inhibitors | |
| EP1816122A3 (en) | 3,4,5-substituted piperidines as therapeutic compounds | |
| WO2004014868A8 (en) | Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors | |
| EA200801199A1 (en) | KINASE INHIBITORS | |
| WO2003053971A8 (en) | Pyridoquinoxaline antivirals | |
| NO20052182L (en) | New connections | |
| GEP20115322B (en) | Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom | |
| DE60225694D1 (en) | FEXOFENADINE HYDROCHLORIDE POLYMORPH | |
| TH72645A (en) | A combination of an SRC inhibitor kinase and a chemotherapy agent for the treatment of proliferation diseases. | |
| NO20070421L (en) | Radiosensitizing agent |